Literature DB >> 10756022

Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A.

C M O'Neal1, G R Harriman, M E Conner.   

Abstract

Immunoglobulin A (IgA) is the primary immune response induced in the intestine by rotavirus infection, but vaccination with virus-like particles induces predominantly IgG, not IgA. To definitively assess the role of IgA in protection from rotavirus infection, IgA knockout mice, which are devoid of serum and secretory IgA, were infected and then rechallenged with murine rotavirus at either 6 weeks or 10 months. Following primary rotavirus infection, IgA knockout mice cleared virus as effectively as IgA normal control mice. Rotavirus-infected IgA knockout mice produced no serum or fecal IgA but did have high levels of antirotavirus serum IgG and IgM and fecal IgG, whereas IgA normal control mice made both serum IgA and IgG and fecal IgA. Both IgA normal and IgA knockout mice were totally protected from rotavirus challenge at 42 days. Ten months following a primary infection, both IgA normal and knockout mice still had high levels of serum and fecal antirotavirus antibody and were totally protected from rotavirus challenge. To determine if compensatory mechanisms other than IgG were responsible for protection from rotavirus infection in IgA knockout mice, mice were depleted of CD4(+) T cells or CD8(+) T cells. No changes in the level of protection were seen in depleted mice. These data show that fecal or systemic IgA is not essential for protection from rotavirus infection and suggest that in the absence of IgA, IgG may play a significant role in protection from mucosal pathogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756022      PMCID: PMC111924          DOI: 10.1128/jvi.74.9.4102-4109.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year.

Authors:  R D Shaw; A A Merchant; W S Groene; E H Cheng
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

2.  Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies.

Authors:  P A Offit; H F Clark
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

3.  Mucosal immunity to influenza without IgA: an IgA knockout mouse model.

Authors:  I N Mbawuike; S Pacheco; C L Acuna; K C Switzer; Y Zhang; G R Harriman
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

4.  Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

Authors:  N Feng; J W Burns; L Bracy; H B Greenberg
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Prevention of rotavirus-induced diarrhea in neonatal mice born to dams immunized with empty capsids of simian rotavirus SA-11.

Authors:  J F Sheridan; C C Smith; M M Manak; L Aurelian
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

6.  Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells.

Authors:  B L Ericson; D Y Graham; B B Mason; M K Estes
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

7.  Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections.

Authors:  M L O'Ryan; D O Matson; M K Estes; L K Pickering
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

8.  Role of coproantibody in clinical protection of children during reinfection with rotavirus.

Authors:  B S Coulson; K Grimwood; I L Hudson; G L Barnes; R F Bishop
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

9.  Rotavirus vaccine administered parenterally induces protective immunity.

Authors:  M E Conner; S E Crawford; C Barone; M K Estes
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Fecal antibody responses to symptomatic and asymptomatic rotavirus infections.

Authors:  D O Matson; M L O'Ryan; I Herrera; L K Pickering; M K Estes
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

View more
  18 in total

1.  B2 but not B1 cells can contribute to CD4+ T-cell-mediated clearance of rotavirus in SCID mice.

Authors:  N Kushnir; N A Bos; A W Zuercher; S E Coffin; C A Moser; P A Offit; J J Cebra
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 2.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

3.  Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication.

Authors:  Yunjeong Kim; Kyeong-Ok Chang
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity.

Authors:  Sarah E Blutt; Kelly L Warfield; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

5.  Secretory antibodies do not affect the composition of the bacterial microbiota in the terminal ileum of 10-week-old mice.

Authors:  Leanne Sait; Maja Galic; Richard A Strugnell; Peter H Janssen
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

6.  HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.

Authors:  Andrea S Laimbacher; Laura E Esteban; Alejandro A Castello; Juan C Abdusetir Cerfoglio; Marcelo H Argüelles; Graciela Glikmann; Alejandra D'Antuono; Nora Mattion; Mabel Berois; Juan Arbiza; Monika Hilbe; Elisabeth M Schraner; Michael Seyffert; Christiane Dresch; Alberto L Epstein; Mathias Ackermann; Cornel Fraefel
Journal:  Mol Ther       Date:  2012-06-19       Impact factor: 11.454

7.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Antibody is critical for the clearance of murine norovirus infection.

Authors:  Karen A Chachu; David W Strong; Anna D LoBue; Christiane E Wobus; Ralph S Baric; Herbert W Virgin
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

10.  Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection.

Authors:  Alicia R Mathers; Christopher F Cuff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.